TI
AMLX icon

Trexquant Investment’s Amylyx Pharmaceuticals AMLX Stock Holding History

Trexquant Investment’s Portfolio AMLX Stock Details AMLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.28M Buy
+349,439
New +$5.4M 0.04% 625
2026
Q1 		– Sell
-48,112
Closed -$581K – 1737
2025
Q4 		$581K Sell
48,112
-174,764
-78% -$2.37M 0.01% 1308
2025
Q3 		$3.03M Buy
+222,876
New +$2.1M 0.03% 740
2024
Q1 		– Sell
-265,046
Closed -$3.9M – 1411
2023
Q4 		$3.9M Buy
+265,046
New +$4.06M 0.09% 327

Other funds holding AMLX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
SVCM
Saturn V Capital Management Austin, Texas $697M AUM 628.57% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Trexquant Investment's AMLX Position: Q2 2026 in Review

Trexquant Investment opened a new position in Amylyx Pharmaceuticals (AMLX) in Q2 2026: 349,439 shares worth $6.28M. The stake represents 0.04% of the portfolio and ranks #625 among its holdings. This is a return to the name: Trexquant Investment previously reported a position in AMLX as recently as Q4 2025.

Trexquant Investment first reported a position in AMLX in Q4 2023 and has held it in 4 quarters since. 206 funds tracked by Wall St. Rank hold AMLX as of Q2 2026.

  • Trexquant Investment held 349,439 shares of Amylyx Pharmaceuticals worth $6.28M as of Q2 2026.
  • Amylyx Pharmaceuticals was a new Trexquant Investment position in Q2 2026.
  • Amylyx Pharmaceuticals made up 0.04% of Trexquant Investment's portfolio in Q2 2026, its #625 holding.
  • Trexquant Investment first reported a position in Amylyx Pharmaceuticals in Q4 2023 and has held it in 4 quarters since.
  • 206 funds tracked by Wall St. Rank held Amylyx Pharmaceuticals as of Q2 2026.

Based on Trexquant Investment's 13F filing for Q2 2026, filed 14 Aug 2026.